Audiological assessment of neonatal hyperbilirubinemia

Int J Pediatr Otorhinolaryngol. 2020 Aug:135:110126. doi: 10.1016/j.ijporl.2020.110126. Epub 2020 May 20.

Abstract

Object: To evaluate the hearing of infants with history of neonatal hyperbilirubinemia using ABR.

Methods: A prospective randomized study carried on 100 infants whose hearing was assessed by ABR. Infants were allocated into two groups; case group which involve 60 infants with history of neonatal hyperbilirubinemia (bilirubin more than17 mg/dl and less than 30 mg/dl) and control group involve 40 healthy infants. Each group was divided into 3 groups based on their age i.e. ≤ 6 months, > 6-9 months &> 9-12 months. The evaluated variables were latency time & inter peak latency time.

Results: The mean latencies of wave III&V of ABR were significantly higher in the case group compared with the controls (P < 0.001) while the mean latencies of wave I did not show a significant difference between the two study groups (P > 0.05). The mean inter wave latencies I-III, I-V& III-V of ABR were significantly higher in the case group compared with the controls. There was a negative correlation between age and the studied variables.

Conclusion: Hyperbilirubinemia have an adverse effect on neonatal hearing which was reflected by ABR parameters of this study.

Keywords: ABR; Hearing loss; Hyperbilirubinemia; Neonate.

MeSH terms

  • Age Factors
  • Bilirubin / blood
  • Case-Control Studies
  • Evoked Potentials, Auditory, Brain Stem*
  • Hearing
  • Humans
  • Hyperbilirubinemia, Neonatal / physiopathology*
  • Infant
  • Infant, Newborn
  • Prospective Studies
  • Reaction Time*

Substances

  • Bilirubin